Journal of Microbiology and Biotechnology
The Korean Society for Microbiology and Biotechnology publishes the Journal of Microbiology and Biotechnology.

2019 ; Vol.29-12: 1916~1924

AuthorJun-Hyeok Yu, Jeong-A Lim, Hyun-Joo Chang, Jong-Hyun Park
Place of dutyepartment of Food Science and Biotechnology, College of BioNano Technology, Gachon University, Republic of Korea
TitleCharacteristics and Lytic Activity of Phage-Derived Peptidoglycan Hydrolase, LysSAP8, as a Potent Alternative Biocontrol Agent for Staphylococcus aureus
PublicationInfo J. Microbiol. Biotechnol.2019 ; Vol.29-12
AbstractOutbreaks of staphylococcal food poisoning (SFP) causing serious human diseases and economic losses have been reported globally. Furthermore, the spread of Staphylococcus aureus with increased resistance to multiple antimicrobial agents has become a major concern in the food industries and medicine. Here, we isolated an endolysin LysSAP8, as one of the peptidoglycan hydrolases, derived from the bacteriophage SAP8 infecting S. aureus. This endolysin was tagged with a 6×His at the C-terminal of the target protein and purified using affinity chromatography. LysSAP8 demonstrated lytic activity against a broad spectrum of bacteria, which included a majority of the staphylococcal strains tested in this study as well as the methicillin-resistant S. aureus (MRSA); however, no such activity was observed against other gram-positive or gram-negative bacteria. Additionally, LysSAP8 could maintain bactericidal activity until 0.1 nM working concentration and after heat treatment at 37°C for 30 min. The ability of LysSAP8 to lyse cells under varying conditions of temperature (4–43°C), pH (3–9), and NaCl concentrations (0–1,000 mM), and divalent metal ions (Ca2+, Co2+, Cu2+, Mg2+, Mn2+, Hg2+, and Zn2+) was examined. At the optimized condition, LysSAP8 could disrupt approximately 3.46 log CFU/ml of the planktonic cells in their exponential phase of growth within 30 min. In this study, we have suggested that LysSAP8 could be a potent alternative as a biocontrol agent that can be used to combat MRSA.
Full-Text
Supplemental Data
Key_wordStaphylococcus aureus, bacteriophage, endolysin, MRSA
References
  1. Knox J, Uhlemann AC, Lowy FD. 2015. Staphylococcus aureus infections: transmission within households and the community. Trends Microbiol. 23: 437-444.
    Pubmed CrossRef Pubmed Central
  2. Argudin MA, Mendoza MC, Rodicio MR. 2010. Food poisoning and Staphylococcus aureus enterotoxins. Toxins (Basel). 2: 1751-1773.
    Pubmed CrossRef Pubmed Central
  3. Choi SW, Lee JC, Kim J, Kim JE, Baek MJ, Park SY, et al. 2019. Prevalence and risk factors for positive nasal methicillin-resistant Staphylococcus aureus carriage among orthopedic patients in Korea. J. Clin. Med. 8(5): pii: E631.
    Pubmed CrossRef Pubmed Central
  4. Hennekinne J-A. 2018. Staphylococcus aureus as a Leading Cause of Foodborne Outbreaks Worldwide, pp. 129-146. In Fetsch A (ed.), Staphylococcus aureus, 1st Ed. Academic Press, Cambridge.
    CrossRef
  5. Hyeon JY. 2013. A foodborne outbreak of Staphylococcus aureus associated with fried chicken in Republic of Korea. J. Microbiol. Biotechnol. 23: 85-87.
    Pubmed CrossRef
  6. Papadopoulos P, Papadopoulos T, Angelidis AS, Boukouvala E, Zdragas A, Papa A, et al. 2018. Prevalence of Staphylococcus aureus and of methicillin-resistant S. aureus (MRSA) along the production chain of dairy products in north-western Greece. Food Microbiol. 69: 43-50.
    Pubmed CrossRef
  7. Lin DM, Koskella B, Lin HC. 2017. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest Pharmacol. Ther. 8: 162-173.
    Pubmed CrossRef Pubmed Central
  8. Salmond GP, Fineran PC. 2015. A century of the phage:past, present and future. Nat. Rev. Microbiol. 13: 777-786.
    Pubmed CrossRef
  9. Jamal M, Bukhari S, Andleeb S, Ali M, Raza S, Nawaz MA, et al. 2019. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields. J. Basic Microbiol. 59: 123-133.
    Pubmed CrossRef
  10. Wittebole X, De Roock S, Opal SM. 2014. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5: 226-235.
    Pubmed CrossRef Pubmed Central
  11. Schmelcher M, Donovan DM, Loessner MJ. 2012. Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 7: 1147-1171.
    Pubmed CrossRef Pubmed Central
  12. Schmelcher M, Loessner MJ. 2016. Bacteriophage endolysins:applications for food safety. Curr. Opin. Biotechnol. 37: 76-87.
    Pubmed CrossRef
  13. Trudil D. 2015. Phage lytic enzymes: a history. Virol. Sin. 30: 26-32.
    Pubmed CrossRef
  14. Chang Y, Yoon H, Kang DH, Chang PS, Ryu S. 2017. Endolysin LysSA97 is synergistic with carvacrol in controlling Staphylococcus aureus in foods. Int. J. Food Microbiol. 244: 19-26.
    Pubmed CrossRef
  15. Jasim HN, Hafidh RR, Abdulamir AS. 2018. Formation of therapeutic phage cocktail and endolysin to highly multidrug resistant Acinetobacter baumannii: in vitro and in vivo study. Iran J. Basic Med. Sci. 21: 1100-1108.
  16. Zhang L, Li D, Li X, Hu L, Cheng M, Xia F, et al. 2016. LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation. Sci. Rep. 6: 29344.
    Pubmed CrossRef Pubmed Central
  17. Gerstmans H, Rodriguez-Rubio L, Lavigne R, Briers Y. 2016. From endolysins to Artilysin(R)s: novel enzyme-based approaches to kill drug-resistant bacteria. Biochem. Soc. Trans. 44: 123-128.
    Pubmed CrossRef
  18. Abaev I, Foster-Frey J, Korobova O, Shishkova N, Kiseleva N, Kopylov P, et al. 2013. Staphylococcal phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lyticdomain secondary translational start site. Appl. Microbiol. Biotechnol. 97: 3449-3456.
    Pubmed CrossRef Pubmed Central
  19. Fujiki J, Nakamura T, Furusawa T, Ohno H, Takahashi H, Kitana J, et al. 2018. Characterization of the lytic capability of a lysk-like endolysin, lys-phiSA012, derived from a polyvalent Staphylococcus aureus bacteriophage. Pharmaceuticals (Basel). 11(1). pii: E25.
    Pubmed CrossRef Pubmed Central
  20. Gu J, Xu W, Lei L, Huang J, Feng X, Sun C, et al. 2011. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin resistant Staphylococcus aureus infection. J. Clin. Microbiol. 49: 111-117.
    Pubmed CrossRef Pubmed Central
  21. Haddad Kashani H, Schmelcher M, Sabzalipoor H, Seyed Hosseini E, Moniri R. 2018. Recombinant endolysins as potential therapeutics against antibiotic-resistant: current status of research and novel delivery strategies. Clin. Microbiol. Rev. 31: e00071-00017.
    Pubmed CrossRef Pubmed Central
  22. Sanz-Gaitero M, Keary R, Garcia-Doval C, Coffey A, van Raaij MJ. 2014. Crystal structure of the lytic CHAP(K) domain of the endolysin LysK from Staphylococcus aureus bacteriophage K. Virol J. 11: 133-133.
    Pubmed CrossRef Pubmed Central
  23. Melo LDR, Brandao A, Akturk E, Santos SB, Azeredo J. 2018. Characterization of a new Staphylococcus aureus kayvirus harboring a lysin active against biofilms. Viruses 10(4). pii: E182.
    Pubmed CrossRef Pubmed Central
  24. Kim NH, Park WB, Cho JE, Choi YJ, Choi SJ, Jun SY, et al. 2018. Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection. Antimicrob. Agents Chemother. 62. pii: e00731-18.
    Pubmed CrossRef Pubmed Central
  25. Lu L, Cai L, Jiao N, Zhang R. 2017. Isolation and characterization of the first phage infecting ecologically important marine bacteria Erythrobacter. Virol J. 14(1): 104.
    Pubmed CrossRef Pubmed Central
  26. Bao H, Zhang P, Zhang H, Zhou Y, Zhang L, Wang R. 2015. bio-control of Salmonella Enteritidis in foods using bacteriophages. Viruses 7: 4836-4853.
    Pubmed CrossRef Pubmed Central
  27. Khan Shawan MM, Hasan MA, Hossain MM, Hasan MM, Parvin A, Akter S, et al. 2016. Genomics dataset on unclassified published organism (patent US 7547531). Data Brief. 9: 602-605.
    Pubmed CrossRef Pubmed Central
  28. Lowe TM, Eddy SR. 1997. tRNAscan-SE: a program for improved detection of transfer rna genes in genomic sequence. Nucleic Acids Res. 25: 955-964.
    Pubmed CrossRef Pubmed Central
  29. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
    Pubmed CrossRef Pubmed Central
  30. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. 2007. Clustal W and clustal X version 2.0. Bioinformatics 23: 2947-2948.
    Pubmed CrossRef
  31. Kumar S, Nei M, Dudley J, Tamura K. 2008. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform. 9: 299-306.
    Pubmed CrossRef Pubmed Central
  32. Cabrita LD, Bottomley SP. 2004. Protein expression and refolding – a practical guide to getting the most out of inclusion bodies, pp. 31-50. In El-Gewely MR (ed.), Biotechnology Annual Review Volume 10., 10 th Ed. Elsevier, Amsterdam.
    CrossRef
  33. Schmelcher M, Shen Y, Nelson DC, Eugster MR, Eichenseher F, Hanke DC, et al. 2015. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. J. Antimicrob. Chemother. 70: 1453-1465.
    Pubmed CrossRef Pubmed Central
  34. Won G, Hajam IA, Lee JH. 2017. Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by coexpression of lambda phage holin-endolysin and X174 gene E. Sci. Rep. 7: 45139.
    Pubmed CrossRef Pubmed Central
  35. Larpin Y, Oechslin F, Moreillon P, Resch G, Entenza JM, Mancini S. 2018. In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria. PLoS One 13: e0192507.
    Pubmed CrossRef Pubmed Central
  36. Dong H, Z hu C , Chen J , Ye X, H uang Y P . 2015. Antibacterial activity of Stenotrophomonas maltophilia endolysin P28 against both gram-positive and gram-negative bacteria. Front Microbiol. 6: 1299.
    CrossRef
  37. Chang Y, Kim M, Ryu S. 2017. Characterization of a novel endolysin LysSA11 and its utility as a potent biocontrol agent against Staphylococcus aureus on food and utensils. Food Microbiol. 68: 112-120.
    Pubmed CrossRef
  38. Filatova LY, Donovan DM, Foster-Frey J, Pugachev VG, Dmitrieva NF, Chubar TA, et al. 2015. Bacteriophage phi11 lysin: physicochemical characterization and comparison with phage phi80alpha lysin. Enzyme Microb. Technol. 73-74: 51-58.
    Pubmed CrossRef
  39. Becker SC, Dong S, Baker JR, Foster-Frey J, Pritchard DG, Donovan DM. 2009. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol. Lett. 294: 52-60.
    Pubmed CrossRef
  40. Gilmer DB, Schmitz JE, Euler CW, Fischetti VA. 2013. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillinresistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57: 2743-2750.
    Pubmed CrossRef Pubmed Central
  41. Heselpoth RD, Yin Y, Moult J, Nelson DC. 2015. Increasing the stability of the bacteriophage endolysin PlyC using rationale-based FoldX computational modeling. Protein Eng. Des. Sel. 28: 85-92.
    Pubmed CrossRef
  42. Gupta R, Prasad Y. 2011. P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections. Curr. Microbiol. 63: 39-45.
    Pubmed CrossRef



Copyright © 2009 by the Korean Society for Microbiology and Biotechnology.
All right reserved. Mail to jmb@jmb.or.kr
Online ISSN: 1738-8872    Print ISSN: 1017-7825    Powered by INFOrang Co., Ltd